Side effects of low-dose cyclosporin A in the treatment of multiple sclerosis

P Bramanti et al. Ital J Neurol Sci. 1990 Feb.

. 1990 Feb;11(1):77.

doi: 10.1007/BF02334910.

No abstract available

Similar articles

Cyclosporin A curtails the progression of free light chain synthesis in the CSF of patients with multiple sclerosis.
McLean BN, Rudge P, Thompson EJ. McLean BN, et al. J Neurol Neurosurg Psychiatry. 1989 Apr;52(4):529-31. doi: 10.1136/jnnp.52.4.529. J Neurol Neurosurg Psychiatry. 1989. PMID: 2500497 Free PMC article. Clinical Trial.
[Efficacy and tolerance of cyclosporin A in the treatment of multiple sclerosis].
Schluep M, Steck AJ, Despland PA, Regli F, Ochsner F, Berrut E, Gauthier G. Schluep M, et al. Schweiz Rundsch Med Prax. 1991 Jun 11;80(24):670-2. Schweiz Rundsch Med Prax. 1991. PMID: 2068440 Clinical Trial. French.
Cyclosporin, blood-brain barrier, and multiple sclerosis.
Fazakerley JK, Webb HE. Fazakerley JK, et al. Lancet. 1985 Oct 19;2(8460):889-90. doi: 10.1016/s0140-6736(85)90153-9. Lancet. 1985. PMID: 2864600 No abstract available.
[Current therapy of multiple sclerosis: value of cyclosporin A and FK 506].
Hohlfeld R. Hohlfeld R. Nervenarzt. 1991 Feb;62(2):136-8. Nervenarzt. 1991. PMID: 1709725 Review. German. No abstract available.
[Immunosuppressive therapy of multiple sclerosis using cyclosporin A and azathioprine. Long-term effects, risks, proton spin tomography and immunological findings].
Kappos L. Kappos L. Schriftenr Neurol. 1990;32:1-200. Schriftenr Neurol. 1990. PMID: 2200108 Review. German. No abstract available.